How to define high risk smoldering myeloma Published 2020-10-03 Download video MP4 360p Download video MP4 720p Recommendations 56:51 Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed 59:54 Will the Smoldering Myeloma Diagnosis Phase Out? 04:59 When is disease a good thing? 1:00:53 How Fast Can Multiple Myeloma Progress and What Biologically Happens When It Does? 06:05 Precursor conditions: management of smoldering myeloma 07:24 Andy, multiple myeloma survivor 04:58 How I Treat Smoldering Multiple Myeloma - Irene Ghobrial, MD 21:56 Monoclonal Gammopathies: What you need to know 22:50 My Multiple Myeloma Diagnosis: "They Weren't the Typical Symptoms" | Julie's Story 1:02:06 Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action 09:22 Myeloma:Interpreting test results | BMJ Learning 32:46 Erin's Multiple Myeloma Story: From Back Pain to a Stage 3 Diagnosis | The Patient Story 04:12 When should smoldering multiple myeloma patients start treatment? 09:25 MGUS diagnosis: a step-by-step approach 18:46 Smoldering Multiple Myeloma: Is it TREATABLE? | What to know about this RARE CANCER 06:13 What blood tests are used to measure myeloma and monitor response? 51:54 Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays... 46:28 Not All M-Spikes are Myeloma 06:25 Smoldering myeloma 14:22 Medical Stories - Multiple Myeloma: Kenny's Story Similar videos 04:04 How is high-risk smoldering multiple myeloma diagnosed? 01:26 Identifying high-risk smoldering myeloma & minimizing treatment-related toxicity 02:37 What Causes Smoldering Myeloma and Who is at High Risk? 01:04 Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma 03:48 The importance of treating patients with smoldering myeloma at high risk of progression to myeloma 06:19 High Risk and Smoldering Multiple Myeloma 03:57 Dr. Ghobrial on identifying high risk in smoldering multiple myeloma |Dana-Farber Cancer Institute 04:05 Managing High-Risk Smoldering Myeloma 03:08 What does it mean to have functional high-risk multiple myeloma? 01:38 Daratumumab in the treatment of high-risk MGUS and low-risk smoldering myeloma 03:04 Identifying high-risk patients with SMM & MGUS to prevent progression to active myeloma 04:40 How do the two approaches to treating high-risk smoldering multiple myeloma (HRSMM) patients differ? 01:11 Understanding the risk of progression of smoldering myeloma to provide more personalized therapies 02:49 Defining high-risk myeloma 01:41 Mitigating smoldering myeloma progression risk 30:45 Smoldering Multiple Myeloma – Defining High Risk and Deciding Who to Treat 02:45 Clinical and genomic diagnosis of smoldering myeloma & identifying patients at risk of progression 02:20 Genomic profiling of smoldering myeloma identifies high- and low- risk patients More results